Color key: green marks multi-state operators. Orange marks branded consumer products. Gold marks CBD-specific brands. Purple marks aggregators and tech. Blue marks devices and accessories.
Source: 5W analysis of AI-generated responses across ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews, Q1 2026. Share represents estimated proportion of brand citations across 50+ tracked consumer prompts. The remaining share splits across ranks 16 to 25, unranked brands, and refused or hedged AI responses.
THE FULL TOP 25 RANKING
1. Curaleaf. Multi-state operator. Approximately 159 to 161 retail locations across 14 U.S. states as of end-Q4 2025 and early 2026 (Curaleaf Holdings Q4 2025 earnings release). The first U.S. MSO to expand internationally, via Curaleaf International. Wide product portfolio across flower, vapes, edibles, and hemp-derived THC beverages. Category leader by AI citation share for "biggest cannabis company" and "national cannabis brand" prompts.
2. Trulieve. Multi-state operator. Over 200 dispensaries with dominant Florida market share, the largest medical cannabis market in the country at 800,000-plus registered patients. Strong presence in Arizona and Pennsylvania. Wins nearly every Florida-specific cannabis prompt.
3. Cookies. Branded consumer products, founded by Berner. The most-cited consumer cannabis brand in U.S. AI answers. Owns the "best cannabis brand" and "premium flower" citation surfaces. Its cultural footprint extends well beyond cannabis-specific media into mainstream lifestyle press.
4. Leafly. Aggregator and information source, founded 2010. The de facto consumer cannabis information source. Its strain database, dispensary finder, and consumer education content are all cited heavily by AI engines, making it a category-defining authority on strain queries.
5. Charlotte's Web. CBD-specific, founded by the Stanley Brothers. The most-cited CBD brand in U.S. AI answers. Its origin story (Charlotte Figi) gives the brand a citation moat in CBD-for-medical-use queries that no challenger has matched.
6. Green Thumb Industries. Multi-state operator with 113 retail stores in 14 states (March 2026). Brand portfolio includes Rythm, Dogwalkers, and Beboe, the most-recognized national consumer cannabis brand portfolio of any MSO, and one of the few consistently profitable cannabis stocks.
7. Weedmaps. Aggregator and information source, the second-largest cannabis aggregator. Stronger geographic penetration in California and West Coast markets than Leafly. Wins "dispensary near me" prompts in California and competing prompts in CA-adjacent states.
8. Wyld. Branded consumer products. Owns the "best cannabis edibles" and "best cannabis gummies" citation surfaces. Distributed in multiple states through licensing agreements with regional MSOs.
9. Stiiizy. Branded consumer products and the vape-category leader. Dominant in California and growing in expansion markets. Wins "best cannabis vape brand" prompts at industry-leading consistency.
10. Kiva Confections. Branded consumer products in premium chocolate and confections. Strong citation share in "luxury cannabis edibles" and gift-occasion prompts.
11. Cresco Labs. Multi-state operator and wholesale cannabis distribution leader. Brand portfolio includes Cresco, Sunnyside, and Mindy's Edibles, with strong Illinois and Pennsylvania presence.
12. Verano Holdings. Multi-state operator with a tiered brand architecture: Verano, Savvy, and Encore. Retail strength in New Jersey and Illinois, where its citation share is concentrated.
13. Cann. Branded consumer products in cannabis-infused beverages. Owns the "cannabis drink" and "cannabis sober-curious" citation niches, and is the most-cited cannabis beverage brand in lifestyle-press AI references.
14. Cornbread Hemp. CBD-specific, based in Kentucky. Strong citation share in "USDA-organic CBD" and "Kentucky CBD" prompts. The closest direct challenger to Charlotte's Web on premium CBD positioning.
15. PAX Labs. Devices and accessories, the dominant cannabis vaporizer hardware brand. Distinct from Stiiizy, which makes vape pens with cannabis oil; PAX makes the device. Strong "best cannabis vaporizer" citation share.
16. Lazarus Naturals. CBD-specific. Strong citation share in "affordable CBD" and "high-potency CBD" prompts.
17. Ascend Wellness. Multi-state operator with strong East Coast retail presence, including Massachusetts and New Jersey. Citation share concentrated regionally.
18. Wana Brands. Branded consumer products in cannabis edibles. Strong citation share in "cannabis gummies" prompts, competing directly with Wyld.
19. CBDistillery. CBD-specific, with mass-market positioning and wide retail distribution. Citation share concentrated in "best CBD on Amazon" and "affordable CBD" prompts.
20. Dutchie. Cannabis tech and e-commerce, the dominant dispensary e-commerce platform, powering thousands of dispensary websites. AI engines cite Dutchie infrastructure indirectly through dispensary citations.
21. Eaze. Aggregator and delivery service focused on California. Citation share concentrated in California-specific delivery prompts.
22. Joy Organics. CBD-specific, with THC-free positioning. Strong citation share in "CBD without THC" and "drug-test-safe CBD" prompts.
23. TerrAscend. Multi-state operator with presence in Pennsylvania, New Jersey, and Maryland. Strong regional citation share in those states.
24. MJBizDaily. Industry information source and the dominant cannabis trade publication. Cited by AI engines for cannabis-industry business prompts and sales statistics.
25. Medterra. CBD-specific, with athletic positioning and an NSF Certified for Sport designation. Strong citation share in "CBD for athletes" and "CBD for recovery" prompts.
KEY FINDINGS
- STAT 1: 25 states plus DC where recreational cannabis is fully legal as of April 2026. 16 additional states operate medical-only programs.
- STAT 2: $47B, the projected U.S. cannabis industry size in 2026.
- STAT 3: $25B, annual U.S. cannabis tax revenue, nearly double alcohol's contribution.
- STAT 4: 425,002 full-time-equivalent jobs supported by legal cannabis in the U.S.
- STAT 5: 17.5%, the estimated combined AI citation share of Curaleaf, Trulieve, and Green Thumb Industries across 50+ tracked queries.
- STAT 6: 28%, the share of cannabis prompts that produced AI engine refusals, disclaimers, or hedges. The highest rate of any category 5W has measured.
- STAT 7: Approximately 160 Curaleaf retail locations across 14 U.S. states (Curaleaf Q4 2025 earnings release, January 2026).
- STAT 8: December 18, 2025, the date President Trump signed the executive order directing rescheduling of cannabis to Schedule III. April 23, 2026, the date DOJ and DEA finalized the order placing FDA-approved marijuana products and state-licensed medical marijuana in Schedule III, with a broader rescheduling hearing scheduled June 29 to July 15, 2026.
WHY DOES CANNABIS PRODUCE THE MOST VOLATILE AI CITATION SURFACE?
Every other major American consumer category 5W has tracked operates under one set of rules. Pickleball paddles ship to Texas the same way they ship to California. Crypto exchanges register with one federal regulator. Pet food sells in Tennessee the same way it sells in New York. Cannabis is the only major consumer category where federal illegality and 25 different state-legal frameworks sit on top of one another. AI engines have absorbed that fragmentation and reflected it back in their citations.
The result is the most volatile AI citation surface 5W has measured. The same query produces different recommendations by state. Some prompts trigger AI hedging or refusals at rates five to ten times higher than any other category. Brand citations that exist for medical cannabis disappear when the prompt mentions recreational use. Citations for CBD products differ from citations for THC products, because the federal-legal distinction is preserved in AI training data. Aggregators such as Leafly and Weedmaps win general "find a dispensary" prompts at rates that compete with the largest MSOs. AI engines treat the aggregator surface as the neutral answer to a federally complicated question.
Inside that fragmented citation surface, 5W's testing surfaced three structural patterns. First, the largest MSOs (Curaleaf, Trulieve, Green Thumb Industries, Cresco Labs, and Verano) have built enough state-by-state retail and brand presence that AI engines default to them in their strongest states. Curaleaf wins national "biggest cannabis company" prompts. Trulieve dominates Florida-specific prompts. Green Thumb owns brand-name prompts for Rythm, Dogwalkers, and Beboe that smaller MSOs cannot match.
Second, branded cannabis consumer products, including Cookies, Cann, Wyld, Stiiizy, and Kiva, have built citation surfaces that operate independently of dispensary brand recognition. A consumer asking "best cannabis edible" gets Wyld and Kiva. A consumer asking "best cannabis dispensary" gets Curaleaf and Trulieve. The two surfaces barely overlap.
Third, the CBD category (Charlotte's Web, Cornbread Hemp, Lazarus Naturals, and CBDistillery) operates as a separate AI citation universe entirely. CBD's federal legal status under the 2018 Farm Bill produces fewer AI hedges than THC queries.
The Trump administration's December 2025 executive order to reschedule cannabis to Schedule III, if implemented in full, will reset the AI citation surface again. Brands that have built consistent, structured, regulatory-credible content across the legal volatility are building durable AI citation share now. Brands waiting for federal clarity are falling further behind.
METHODOLOGY
5W analyzed more than 50 common cannabis-buyer prompts across five sub-categories. The team identified which brands AI models consistently surface and which editorial and authoritative sources feed those citations. It also tracked where AI engines hedge or refuse to answer, and where the largest gaps sit between commercial scale and AI visibility.
Sub-categories tracked.
U.S. multi-state operators (MSOs): Curaleaf, Trulieve, Green Thumb Industries, Cresco Labs, Verano Holdings, Ascend Wellness, Columbia Care, Jushi Holdings, TerrAscend, and Schwazze. Branded cannabis consumer products: Cookies, Cann, Wyld, Stiiizy, Kiva Confections, Wana Brands, Select, PAX Labs, Dogwalkers, Rythm, and Beboe. CBD-specific brands: Charlotte's Web, Cornbread Hemp, Lazarus Naturals, CBDistillery, Joy Organics, and Medterra. Dispensary aggregators and tech: Leafly, Weedmaps, Eaze, Dutchie, Jane Technologies, Headset, and Flowhub. Industry references and information sources: NORML, Marijuana Moment, MJBizDaily, NCIA, and USDA hemp resources.
Query types tracked.
5W tested real-world buyer-intent prompts, including the examples below, plus more than 35 additional variations covering medical applications, state-specific availability, product selection, education, and brand-comparison intent.
- "Best cannabis dispensary near me"
- "Best cannabis brand for beginners"
- "Where to buy cannabis legally in [state]"
- "Best cannabis edibles" and "best cannabis vape brand"
- "Cannabis vs CBD difference"
- "Best CBD oil" and "best CBD for sleep"
- "Curaleaf vs Trulieve" and "Charlotte's Web vs Cornbread Hemp"
- "Is cannabis legal in Texas, Florida, or Pennsylvania"
- "How to get a medical cannabis card"
- "Cannabis dosing for beginners"
- "Cannabis for anxiety" and "cannabis for chronic pain"
Citation sources tracked.
5W tracked citations across these source types:
- Aggregator and dispensary-finder platforms: Leafly, Weedmaps, Dutchie, Eaze
- Specialist cannabis editorial: MJBizDaily, Cannabis Business Times, Marijuana Moment, Green Market Report, Cannabis Dispensary
- Business press cannabis coverage: Forbes Cannabis, Bloomberg, Investing News Network, The Motley Fool
- CBD-specific editorial: Healthline, Forbes Health, Medical News Today
- State regulator websites
- Industry advocacy groups: NORML, NCIA, Marijuana Policy Project
- Brand-owned content hubs and education centers
Important framing.
This index measures AI citation share for marketing and communications strategy. It does not rank brands on product quality, regulatory compliance, medical efficacy, or consumer suitability. Cannabis purchase decisions should be informed by direct consultation with healthcare providers for medical use. State regulatory disclosures and qualified legal advice matter too, given federal-state legal complexity.
WHICH CANNABIS BRANDS ARE WINNING, AND WHY?
The MSO citation tier: Curaleaf, Trulieve, and Green Thumb Industries. These three brands together account for an estimated 17.5% of all cannabis-category AI citations across the 50+ tracked queries. Curaleaf wins on national footprint, with approximately 160 retail locations across 14 states plus international expansion via Curaleaf International. Trulieve wins on Florida dominance. The state has 800,000-plus registered medical patients, the largest medical cannabis market in the country. Trulieve's in-state market share is strong enough to produce near-uniform AI citations on Florida-specific prompts. Green Thumb Industries wins on consumer brand portfolio, since Rythm, Dogwalkers, and Beboe each have independent citation surfaces that smaller MSOs cannot replicate. The three-way MSO citation tier is separated by a wide margin from MSOs ranked 4 through 10, including Cresco, Verano, Ascend, Columbia Care, Jushi, TerrAscend, and Schwazze.
Cookies' consumer-product citation lock. Cookies is the most-cited consumer cannabis brand in U.S. AI answers, and the gap to the second-place consumer-product brand, Wyld, is wider than the gap between Curaleaf and Trulieve at the MSO tier. The mechanism is cultural: Cookies founder Berner has built brand recognition that extends well beyond cannabis-specific media into mainstream lifestyle, hip-hop, and fashion press. AI engines absorb that cross-category coverage and surface Cookies in "best cannabis brand" prompts at a rate that pure-play cannabis brands struggle to match.
Charlotte's Web's CBD citation moat. Charlotte's Web has held the number one position in CBD AI citations for five years, and the moat is widening, not narrowing. The Charlotte Figi origin story produces a citation density in CBD-for-medical-conditions prompts that no other CBD brand matches. The brand's 2018 Farm Bill positioning, as fully legal hemp-derived CBD, gives it cleaner AI citation behavior than THC-adjacent CBD products. Charlotte's Web is to CBD what Coca-Cola is to cola: the category-defining brand whose name is a near-synonym for the product class.
Leafly and Weedmaps' aggregator dual moat. Cannabis aggregators occupy a structurally favorable position in AI answers, because federal-state legal complexity makes AI engines reluctant to recommend specific dispensaries directly. Leafly wins national prompts and education-focused queries. Weedmaps wins California and West Coast geographic prompts. Together, the two aggregators capture more total cannabis AI citations than any single MSO. The AI sees them as neutral information rather than commercial recommendations, which earns them citation surface that direct retailers cannot win.
Branded consumer products operate independently of MSO citations. Wyld, Stiiizy, Kiva, Cann, and Wana each operate in citation surfaces that barely overlap with MSO citations. A consumer asking "best cannabis brand" gets a different answer than "best cannabis dispensary." That split is a strategic feature, not a flaw. Branded consumer products that license through multiple MSOs build citation moats that survive any single MSO's retail troubles. Cookies, Wyld, and Stiiizy are all distributed through multiple competing MSOs across multiple states.
WHICH CANNABIS BRANDS ARE FALLING BEHIND?
Mid-tier MSOs after the Trump rescheduling executive order. Cresco Labs, Verano Holdings, Ascend Wellness, Columbia Care, Jushi Holdings, TerrAscend, and Schwazze all face the same structural challenge. AI citations for "biggest cannabis company" and "best cannabis dispensary" route to Curaleaf, Trulieve, and Green Thumb Industries with striking consistency. Mid-tier MSO citations need state-specific or product-specific framing just to surface at all. The December 2025 Trump executive order on rescheduling will benefit the entire MSO category, but it will not erase the citation moat the top three have built.
Independent dispensaries. The U.S. has approximately 14,000 licensed cannabis retailers across legal states, and almost none of them appear in AI citations. AI engines route "dispensary near me" prompts to aggregators such as Leafly and Weedmaps, and to the largest MSOs operating retail in the prompted state. That gap will widen as MSO retail consolidation continues.
Newer CBD brands. The CBD category attracted hundreds of brands during the post-2018-Farm-Bill expansion. AI citations have consolidated around six brands: Charlotte's Web, Cornbread Hemp, Lazarus Naturals, CBDistillery, Joy Organics, and Medterra. Newer entrants face a citation moat that mass-retail distribution alone does not break. CBD brands launched after 2022 with limited editorial coverage are essentially invisible in AI answers.
Cannabis brands without state-specific compliance content. 5W's testing found that state-specific content depth is the largest single predictor of AI citation share inside cannabis. Brands with detailed state-by-state retail availability, qualifying-condition guides for medical states, and adult-use-versus-medical distinction content earn citation surface that brands with generic content cannot match. Most cannabis brands have not invested in state-specific content at the level the AI citation surface rewards.
Cannabis brands relying on social media for citation reach. Cannabis brands operate under platform restrictions, since Instagram, Facebook, and TikTok all restrict cannabis content. That restriction has historically pushed brand investment into earned media and direct-to-consumer email. AI engines do not weight social-media presence for cannabis brands the way they do for unrestricted categories. Brands built on platform-restricted social have weak AI citation profiles even when their consumer awareness is strong.
THE SIX STRUCTURAL FINDINGS
1. AI engines refuse or hedge about 28% of cannabis prompts, the highest rate of any category 5W has measured. Federal Schedule I status produces AI citation behavior unlike any other consumer category. Some prompts produce direct refusals. Others produce hedged answers with prominent disclaimers. Others produce confident answers. That hedge rate creates an opening for brands that publish content on exactly the topics AI engines hedge on, such as medical use, dosing, and state-specific legality. Those brands earn citation share that hedge-avoiding brands cannot match.
2. State-specific content depth is the largest single driver of cannabis AI citation share. Brands with structured state-by-state legal content, qualifying-condition guides, and adult-use-versus-medical distinction content outperform brands with generic content. Per 5W's testing, the state-specific content multiplier in cannabis is approximately 2.8x, larger than the equivalent multipliers 5W has measured in less-fragmented categories.
3. Branded consumer products operate in separate citation surfaces from MSO retail. "Best cannabis brand" and "best cannabis dispensary" return materially different answers. Brands that win consumer-product citations, including Cookies, Wyld, Stiiizy, Kiva, and Cann, build licensing moats that survive individual MSO troubles. That is a strategic feature for brands and a strategic vulnerability for MSOs that rely on owned brands rather than third-party licensed brands.
4. CBD operates as a separate AI citation universe from THC cannabis. The 2018 Farm Bill's federal legalization of hemp-derived CBD produces fewer AI hedges than THC queries. CBD-specific brands, including Charlotte's Web, Cornbread Hemp, Lazarus Naturals, CBDistillery, Joy Organics, and Medterra, compete in a separate citation surface from THC brands. Brands that try to span both categories typically lose citation share in both, compared with specialists.
5. Aggregators capture more aggregate citation share than the largest individual MSOs. Federal-state legal complexity makes AI engines route "find a dispensary" prompts to aggregators such as Leafly and Weedmaps rather than to direct retailers. This aggregator advantage is structural, and 5W expects it to persist even with full federal legalization, because the cross-state navigation problem aggregators solve will remain.
6. The December 2025 executive order on cannabis rescheduling produced the largest single citation reset in cannabis since legalization began. AI models trained on post-Q1-2026 data weight the rescheduling narrative heavily. Brands that produced rescheduling-relevant content, covering regulatory implications, business impact, and medical research access, built citation surface that brands silent on rescheduling cannot match.
WHAT CHANGED FOR CANNABIS AI CITATION IN 2026?
1. The December 2025 rescheduling executive order, and the April 23, 2026 DOJ and DEA finalization order, is the year's largest citation event. AI answers about "cannabis legalization," "Schedule III cannabis," and "cannabis federal status" now reference the executive order and the DOJ finalization in nearly every response. Brands that produced rescheduling-aligned content in Q1 2026 captured citation share that earlier-published content alone could not generate. The broader rescheduling hearing scheduled June 29 to July 15, 2026 will be the next major citation reset.
2. Florida's 2026 ballot initiative failure reset Florida-specific citation patterns. The Florida Supreme Court's March 2026 decision declining to review the recreational legalization ballot appeal preserved Trulieve's medical-only Florida moat for at least another two years. AI answers about "Florida cannabis" now route to Trulieve more reliably than during the active ballot campaign.
3. Virginia's March 2026 retail framework approval, with sales beginning January 2027, is reshaping Virginia-specific citation patterns. The first MSOs to publish Virginia-specific content captured citation share for "Virginia cannabis dispensary" prompts that will compound through the retail launch.
4. Cannabis has not had a category-defining trust event comparable to the 2025 crypto exchange hacks. The result is that AI engines do not weight security signals heavily in cannabis citations, and instead focus on regulatory and legal signals.
5. Massachusetts's 2026 anti-recreational ballot campaign reset Massachusetts-specific citation patterns. The campaign attempting to roll back the state's 2016 recreational legalization produced citation events that AI engines absorbed. Brands operating in Massachusetts that produced "case for adult-use cannabis" content earned citation share that will outlast the ballot campaign.
6. Cookies' continued cultural footprint expansion is widening its consumer-product citation lead. Brand collaborations, music industry presence, and lifestyle-press coverage in 2025 and 2026 produced citation reinforcement that no other cannabis brand has matched. The gap between Cookies and every other consumer brand is widening.
FROM RONN TOROSSIAN, FOUNDER OF 5W
"Cannabis is the most legally fragmented major consumer category in America, and that fragmentation has produced the most volatile AI citation surface we've ever measured. Twenty-eight percent of cannabis prompts produce AI hedges or refusals, five to ten times higher than any other category. The brands winning citation share are the ones that build content addressing exactly the topics AI engines hedge on: state-specific legality, medical applications, dosing, drug interactions. The brands waiting for federal clarity are losing citation surface every quarter to brands that built infrastructure during the volatility. The rescheduling executive order resets the surface again. The window stays open for the brands paying attention. It closes for the rest."
THE CANNABIS GEO PLAYBOOK
1. Audit AI citation share monthly, by state. Cannabis AI citation share varies by state more than any other category 5W has measured. A national audit misses material gaps. State-by-state audits across the 25 adult-use and 16 medical-only states reveal citation gaps that national rollups conceal. Why it works: a national figure averages away the state-level swings 5W's Q1 2026 testing found. Only a state-by-state audit shows where a brand is actually winning or losing.
2. Publish state-specific legal and qualifying-condition content. Per 5W's Q1 2026 testing, the 2.8x state-specific content multiplier is the largest signal effect 5W has measured in cannabis. Brands need state-by-state retail availability pages, medical qualifying-condition guides, and adult-use-versus-medical distinction content. Generic national content underperforms state-specific content by roughly three to one. Why it works: AI models retrieve the most specific matching page for a state-flavored query, so a page written for "Illinois medical cannabis card requirements" outranks a national page for that query every time.
3. Address the topics AI engines hedge on. About 28% of cannabis prompts produce AI hedges or refusals. Brands that publish credentialed-author content on dosing, drug interactions, medical applications, and state-by-state legality earn citation share in prompts where competitors have left a vacuum. Why it works: when an engine is uncertain, it leans on the most authoritative available source rather than staying silent, so credentialed content fills the vacuum other brands leave open.
4. Win one product surface deeply before competing broadly. Cookies owns flower. Wyld owns gummies. Stiiizy owns vapes. Kiva owns chocolate. Cann owns drinks. Wana owns gummies regionally. Brands that try to be category generalists lose to brands that own a specific product sub-surface. Why it works: 5W's ranking data shows each product-specific leader holds a wider citation gap over its nearest rival than any generalist brand holds over anyone.
5. CBD brands should commit to a single category position. Charlotte's Web's CBD-only positioning produces a clearer AI citation signal than brands that span CBD and THC. CBD brands that commit to the federal-legal hemp positioning earn citation share that brands trying to span THC dilute. Why it works: the 2018 Farm Bill draws a hard federal line between hemp-derived CBD and THC, and AI engines mirror that line by hedging THC-adjacent content more than CBD-only content.
6. Treat regulatory events as citation events. The rescheduling executive order, state legalization initiatives, and qualifying-condition expansions all produce citation resets. Calendar AI-citation audits within 72 hours of every major regulatory event. Why it works: 5W's testing found the December 2025 executive order reset AI answers about cannabis legal status within one prompting cycle. A delayed audit misses the window when content updates carry the most weight.
7. Branded consumer-product brands should pursue multi-MSO licensing. Cookies, Wyld, and Stiiizy distribute through multiple competing MSOs across multiple states. The multi-MSO licensing strategy produces broader retail availability and broader AI citation share than single-MSO partnerships. Why it works: distribution through several MSOs multiplies the state-specific pages and dispensary listings that carry a brand's name, and each one is a separate citation opportunity.
8. Maintain aggregator partnerships. Leafly and Weedmaps each capture more aggregate citations than any individual MSO except Curaleaf. Brands that maintain consistent, current, and comprehensive presence on both aggregators earn citation share through that surface that brand-owned content alone cannot generate. Why it works: AI engines treat Leafly and Weedmaps listings as neutral third-party information rather than brand marketing, so a complete listing on both sites feeds citations that a brand's own website cannot.
9. Build for the medical-cannabis-curious consumer. "Cannabis for anxiety," "cannabis for chronic pain," "cannabis for sleep," and "medical cannabis card [state]" are among the highest-volume cannabis queries 5W tracked. Brands that publish credentialed-physician-bylined content on medical applications win citation share that lifestyle-positioned brands do not. Why it works: AI engines weight medical claims toward credentialed sources more heavily than lifestyle content, per the hedge-rate pattern in this Index's Q1 2026 testing.
10. Build for the post-rescheduling consumer now. If federal rescheduling proceeds on the timeline set by the April 2026 DOJ and DEA order, the AI citation surface will reset again. Brands that publish post-rescheduling-ready content, covering federal-tax implications, banking implications, and interstate-commerce implications, build citation surface that brands waiting for rescheduling to occur cannot match. Why it works: the same pattern that followed the December 2025 executive order, first movers captured citation share before competitors published, will repeat at the next hearing scheduled for June 29 to July 15, 2026.
THE BIGGER PICTURE
The American cannabis industry is doing in twelve years what alcohol took eighty years to do after Prohibition. It is establishing a durable set of consumer-facing brands, a state-by-state retail framework, a medical-versus-adult-use distinction, a network of ancillary services, and a federally evolving legal status. In every other consumer category, brand formation was mediated by national press, retail availability, and the slow accretion of consumer recognition over decades.
Cannabis does not have that luxury of time. Federal-state legal fragmentation, AI engine hedging, and regulations that shift quarterly produce a citation surface that rewards brands building infrastructure deliberately and penalizes brands waiting for clarity.
Based on 5W's Q1 2026 testing, the brands positioned to win the next decade share five habits: state-specific content, addressing the topics AI engines hedge on, a single category position (CBD-only, THC-only, beverage-only, or edible-only), multi-MSO licensing, and treating every regulatory event as a citation event. Brands that wait for federal rescheduling to invest in citation infrastructure will find the window already closing. Curaleaf, Trulieve, Green Thumb, Cookies, Charlotte's Web, Leafly, Weedmaps, and a small number of others have already absorbed a growing share of what consumers see when they ask an AI engine where to buy, what to buy, and whether cannabis is legal where they live.
AI citation share is the scoreboard. In cannabis, uniquely among the major American consumer categories 5W has studied, that scoreboard is shaped as much by federal-state legal volatility as by brand investment.
ABOUT 5W
5W is the AI Communications Firm, building brand authority across the platforms where decisions now happen: ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews, alongside earned media, digital, and influencer channels. 5W combines public relations, digital marketing, Generative Engine Optimization (GEO), and proprietary AI visibility research, helping clients measure and grow their presence in AI-driven buyer research.
Founded more than 20 years ago, 5W has been recognized as a top U.S. PR agency by O'Dwyer's, named Agency of the Year in the American Business Awards®, and honored as a Top Place to Work in Communications in 2026 by Ragan. 5W serves clients across B2C sectors including Beauty & Fashion, Consumer Brands, Entertainment, Food & Beverage, Health & Wellness, Travel & Hospitality, Technology, and Nonprofit; B2B specialties including Corporate Communications and Reputation Management; as well as Public Affairs, Crisis Communications, and Digital Marketing, including Social Media, Influencer, Paid Media, GEO, and SEO. 5W was also named to the Digiday WorkLife Employer of the Year list.
For more information, visit 5wpr.com.
FAQ
What is the Cannabis AI Visibility Index?
The Cannabis AI Visibility Index is a 5W research report ranking the top 25 brands in the U.S. cannabis industry by estimated AI citation share across ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews. It measures which brands AI answer engines surface for consumer-intent prompts about dispensaries, products, CBD, medical use, and state-specific legality.
Which MSOs rank highest?
Curaleaf, Trulieve, and Green Thumb Industries lead all multi-state operators by a wide margin. Together they account for an estimated 17.5% of all cannabis-category AI citations across the 50+ tracked queries.
Which consumer brand ranks highest?
Cookies leads all branded cannabis consumer products by a wide margin. Wyld, Stiiizy, Kiva Confections, and Cann complete the top five branded consumer products.
Which CBD brand ranks highest?
Charlotte's Web is the highest-ranked CBD brand and the number five brand in the index overall. The Charlotte Figi origin story and 2018 Farm Bill positioning produce a citation moat in CBD-for-medical-conditions prompts that no challenger has matched in five years.
How was AI citation share measured?
5W ran 50+ consumer-intent prompts through ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews in Q1 2026. The team measured the frequency of brand citations across all responses, including state-specific variations and AI engine hedges or refusals. Citation share is the proportion of total brand mentions captured by each brand.
Why does AI citation share matter for cannabis brands?
Cannabis is the most legally fragmented major consumer category in America. AI engines reflect that fragmentation by hedging or refusing about 28% of cannabis prompts, a higher rate than any other category 5W has measured. Brands that build citation infrastructure across the volatility win durable category positioning that brands waiting for federal clarity cannot match.
Is the report free?
Yes. The web version is free to read and the PDF download is ungated. An optional email signup for future 5W research sits next to the download link.
Can 5W run a Generative Engine Optimization program for my cannabis brand?
Yes. 5W details its Generative Engine Optimization practice on its site, and offers cannabis-specific GEO services through its Cannabis PR and Digital Marketing practice.
Why now?
The citation window is narrow, and regulatory volatility creates a compounding advantage for early movers. AI engines concentrate citations in a small number of domains per topic, and the cannabis AI citation surface resets with every regulatory event. Cannabis brands that invest in the next six months will be cited for years.
Download the full PDF
